Immunotherapies for Acute Myeloid Leukemia

Immunotherapies_for_Acute_Myeloid_Leukemia.jpg

Dublin Core

Title

Immunotherapies for Acute Myeloid Leukemia

Subject

Leukemia

Description

The efficacy of immunotherapeutic approaches in the treatment of different cancer types is becoming increasingly obvious, and immunotherapies in cancer treatment have experienced a significant breakthrough in the last few years. Immunotherapy encompasses several diverse treatment approaches, each of which has a distinct mechanism of action, and all of which are designed to boost or restore immune function in some manner. Consequently, T cell activating immunotherapeutic approaches like immune checkpoint inhibition, chimeric antigen receptor T cells (CARs), or bi-specific T cell activating antibodies are becoming increasingly important treatment strategies in different solid tumor types as well as in hematological malignancies. T cell responses against malignant cells play a major role in maintaining remission and prolonging overall survival in patients after allogeneic stem cell transplantation and donor lymphocyte infusions (DLI) due to the graft-versus-leukemia effect. In acute myeloid leukemia (AML) after intensive chemotherapy, most patients achieve complete remission; however, the overall survival for all AML patients, especially in elderly patients, is still relatively low. Immunotherapeutic approaches for AML patients might be options to reduce the relapse rate and improve overall survival. This Special Issue will focus on immunotherapeutic approaches in AML in established therapies, like the allogeneic stem cell transplantation including new concepts improving the graft-versus-leukemia effect, but also on new efforts to improve immune responses like adoptive T cell transfer, immune checkpoint inhibition, bi-specific antibodies, and CAR-T-cell approaches.

Creator

Greiner, Jochen (editor)

Source

https://directory.doabooks.org/handle/20.500.12854/68750

Publisher

MDPI - Multidisciplinary Digital Publishing Institute

Date

2020

Contributor

Dewi Puspitasari

Rights

https://creativecommons.org/licenses/by/4.0/

Relation

Estey, E.; Döhner, H. Acute myeloid leukaemia. Lancet 2006, 368, 1894–1907. [CrossRef]

Format

Pdf

Language

English

Type

Textbooks

Identifier

DOI
10.3390/books978-3-03936-111-3
ISBN
9783039361106, 9783039361113

Coverage

Basel

Document Viewer